Ann: Gold Technology for Immune Response Cancer Therapy Licensed, page-2

iQ3Corp Ltd ...has received licensing for a gold compound platform technology that induces the body’s immune system to destroy cancer cells.

A gold compound platform technology you say. Immunogenic you say. Do go on...

Our Gold compound platform will allow us to design compounds that specifically target these (auxiliary) mechanisms (as opposed to the compound’s primary function)

Ooh, sounds technical. Tell me more...

This new class of gold-based proprietary compounds represents a unique mechanism of immunotherapy action, in that the cancer cells
are attacked in conjunction with the human body’s natural immune system. The gold-based compounds have the ability to enter cancer
cells and fight them from the inside while disrupting the tumours, making them visible to the human immune system. This disruption starts
a cascade to create killer T-cells that then attack and destroy the remaining cancer.

Unique you say, novel too...but not worth a light scientific explanation to the loyal punters - just some immunotherapy motherhood statements. The language here is starting to make out this is some kind of immuno-god killer. My bullshit-o-meter is tingling.

“This technology is very novel in terms of design, approach, and potential applications

Is this just another mumbo jumbo puff piece? The complete lack of specificity regarding the 'platform' confirms to me that this whole ann is founded on lab-based tinkering which may, or may not, make it to pre-clinical evaluations at some stage and, if having some value, may, or may not move into a human trial. In other words, so far removed from commercial relevance to be totally unworthy of a market release.

Dr. George Syrmalis, said, “I speculate that this mode of action may emerge as a mainstream of cancer treatment in the near future."

Yeah, well...right...say no more friend